@FRPonziani
FROM RESEARCH TO GUIDELINES 🚀
Proud moment for our team: our study on surgical resection for multinodular BCLC-A #HCC [1] — one of the largest Western matched-cohort analyses — is making waves far beyond its first publication.
🔹 Invited Editorial [2]: praised our methodological rigor, our challenge to restrictive BCLC recommendations, and our role in advancing the Multiparametric Therapeutic Hierarchy.
🔹 Guideline Citations: now included in the latest ESMO 2025 [3] and EASL 2025 [4] HCC guidelines.
🔹 Global Review: featured in CA: A Cancer Journal for Clinicians [5], the world’s top-impact oncology journal, as part of the evolving landscape of surgical management in HCC.
This recognition confirms the growing role of evidence-based expansion of surgical indications for carefully selected multinodular HCC patients — a paradigm shift influencing clinical practice worldwide. 🌍
Grateful to my co-authors, collaborators, and the international HCC community for embracing this debate and moving towards more personalized, curative strategies.
#LiverCancer #HCC #Oncology #Surgery #ESMO #EASL #MedicalResearch #Guidelines #EvidenceBasedMedicine
[1]jamanetwork.com/journals/jamas…
[2]hbsn.amegroups.org/article/view/1…
[3] annalsofoncology.org/article/S0923-…
[4] journal-of-hepatology.eu/article/S0168-…
[5]acsjournals.onlinelibrary.wiley.com/doi/10.3322/ca…View quoted post on X
